MM-329 Daratumumab + Bortezomib/Lenalidomide/Dexamethasone (D-VRd) in Transplant-Eligible (TE) Patients With Newly Diagnosed Myeloma (NDMM): Analysis of the Phase 3 PERSEUS Study Based on High-Risk Cytogenetic Abnormalities (HRCAs)
医学
达拉图穆马
来那度胺
硼替佐米
内科学
肿瘤科
地塞米松
多发性骨髓瘤
作者
Meletios Α. Dimopoulos,Pieter Sonneveld,Paula Rodríguez‐Otero,Hang Quach,P. Joy Ho,Meral Beksaç,Cyrille Hulin,Elisabetta Antonioli,Xavier Leleu,Silvia Mangiacavalli,Aurore Perrot,Michèle Cavo,Angelo Belotti,Annemiek Broijl,Francesca Gay,Roberto Mina,Inger S. Nijhof,Niels W.C.J. van de Donk,Eirini Katodritou,Fredrik Schjesvold
PDF的下载单位、IP信息已删除
(2025-6-4)
DW
无极微光
秋风
xing_xing
aaaa
Nole
cdercder
学术文献互助
Criminology34
安详香旋
李杰杰
Enigma_GEB
修仙中
OK
昏睡的蟠桃
the_coco
Lo
我能私信骂你吗
科研狗
初景
皖公网安备34019202002308
